STAT3 and breast carcinoma: MSCs have been reported to exert their negative impact on breast cancer by impairing angiogenesis via secretion of exosomes [99], reducing migration and invasion via the release of tissue inhibitor of metalloproteinase (TIMPs) [100], and decreasing breast tumor growth via down regulation of the STAT3 signaling pathway [101].